Potentially important contribution of dextrose used as diluent to hyperglycemia in hospitalized patients [3]

Diabetes Care

Volumn 28, Issue 4, 2005, Pages 981-982

  Krajicek, Bryan J ^a   Kudva, Yogish C ^b,c   Hurley, Heather A ^b  

^a ST MARY S HOSPITAL   (United States)

^b Mayo Clinic   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; AMINOPHYLLINE; ARGATROBAN; AZITHROMYCIN; CEPHALOSPORIN; CIMETIDINE; CIPROFLOXACIN; CLINDAMYCIN; CYCLOSPORIN; DILUENT; DOBUTAMINE; DOPAMINE; DOXYCYCLINE; ESMOLOL; GLUCOSE; HEPARIN; IBUTILIDE; INSULIN; LIDOCAINE; NESIRITIDE; NORADRENALIN; OCTREOTIDE; PENICILLIN G; PROSTAGLANDIN E1; SODIUM CHLORIDE; STEROID; VALPROIC ACID; VANCOMYCIN;

DRUG EFFECT; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; INSULIN INFUSION; INTENSIVE CARE; LETTER; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; RESPIRATORY FAILURE; RISK REDUCTION;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INPATIENTS; INSULIN; MALE; RESPIRATORY INSUFFICIENCY;

EID: 15944406080     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.4.981     Document Type: Letter

References (4)

1. American College of Endocrinology: American College of Endocrinology Consensus Development Conference on Inpatient Diabetes and Metabolic Control: position statement [article online], 2003. Availablefromhttp://www.aace.com/pub/ ICC/inpatientStatement.php
2. Trissel L: Handbook of Injectable Drugs. 12th ed. Bethesda, MD, American Society of Heath-Systems Pharmacists, 2003
3. Krinsley J: Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 78:1471-1478, 2003
4. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359-1367, 2001